ARTMS is a developer of technology that transforms the production of diagnostic imaging isotopes.
ARTMS is a developer of technology that transforms the production of diagnostic imaging isotopes. Artms provides the QUANTM Irradiation SystemTM (QISTM), which enables decentralized, and local production of important medical isotopes including gallium-68 (68Ga), zirconium-89 (89Zr), technetium‐99m (99mTc) and copper-64 (64Cu).
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
May 20, 2020 | Series A | $19M | 1 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Global health sciences venture fund | — | Series A |